Latest News

  • KALBE PROMOTE NON-PORCINE ENOXAPARIN AS A BLOOD THINNER MEDICATION

    Wednesday, April 13, 2022
    KALBE PROMOTE NON-PORCINE ENOXAPARIN AS A BLOOD THINNER MEDICATION

    Jakarta, April 13th, 2022. PT Kalbe Farma Tbk (Kalbe), in collaboration with PT Metiska Farma, improves access to medicine for the society by promoting Antiten-A, a blood thinner medication or an anticoagulant that contains enoxaparin. This medication can limit the activity of protein for blood-clotting, preventing the formation of a blood clot.

  • KALBE DECLARE KIDNEY HEALTH FOR ALL

    Saturday, April 2, 2022
    KALBE DECLARE KIDNEY HEALTH FOR ALL

    Jakarta, April 2nd, 2022. PT Kalbe Farma Tbk (Kalbe), through Kalbe Ethical Customer Care (KECC), declares kidney health for all in commemorating the World Kidney Day of 2022. This event is a collaboration of Kalbe with the Indonesia Kidney Care Club (IKCC) and the Siloam Hospital of Simatupang.

  • KALBE BOOKED NET PROFIT GROWTH OF 16,5% IN 2021

    Thursday, March 31, 2022
    KALBE BOOKED NET PROFIT GROWTH OF 16,5% IN 2021

    Jakarta, March 31, 2022 – PT Kalbe Farma Tbk and Subsidiaries (“Kalbe” or “the Company”) today announced that net sales reached Rp 26,261 billion in 2021, growing by 13.6% compared to 2020. Meanwhile, net income of the owners of the parent entity reached Rp 3,184 billion in 2021, grew by 16.5% compared to Rp 2,733 billion in 2020. 

RSS
First34567Last